Advertisement
The Lancet Public Health

About The Lancet Public Health

About the journal

The Lancet Public Health is a online-only, open access title in The Lancet's growing family of specialty journals. Building on the foundation of The Lancet as a champion of public health research, this monthly journal is committed to publishing high-quality original Research Articles, Editorials, Comments, and Correspondence that contribute to advancing health equity, public health practice and policy making worldwide. The journal is indexed/abstracted in the DOAJ, MEDLINE/PubMed, Scopus, and in the Journal Citation ReportsTM.

Reputation and Impact

The Lancet Public Health has an Impact Factor of 16.292® (2019 Journal Citation Reports®, Clarivate Analytics 2020).

Information for Authors

The Lancet Public Health publishes high-quality original research, comment, and correspondence that can advance public health policies and outcomes. Wherever possible, figures and good quality photographs (colour or black and white) should be used to supplement and to enhance the text. We also welcome videos. Further details on the different sections of The Lancet Public Health, and how to submit to the journal, are provided below. If you require further clarification, the journal’s editorial staff will be pleased to help (email [email protected]).

Manuscripts must be solely the work of the author(s) stated, must not have been previously published elsewhere, and must not be under consideration by another journal. The Lancet journals are signatories of the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, issued by the International Committee of Medical Journal Editors (ICMJE Recommendations) and to the Committee on Publication Ethics (COPE) code of conduct for editors. We follow COPE's guidelines.

Article processing charges

No subscription or pay-per-view charges apply to any content published in The Lancet Public Health. In order to cover the costs of reviewing, copy editing, layout, and online hosting and archiving, the journal charges an article processing fee of $5000 upon acceptance of submitted research articles, reviews and health policy articles (no fee applies to Comment or Correspondence).

Authors whose main funder is located either in group A or B countries of the Health Inter Network Access to Research Initiative (HINARI) or in a country with a low UNDP human development index will be exempt from payment. For authors with no formal funding, the country of origin of the majority of authors' institutions will be taken as the source country. If there is no majority country, the corresponding author's country will be so designated.

The editorial decision to accept is taken well before any request is made as to the ability to pay. Payments are processed by a department unconnected to The Lancet Public Health's editorial department.

Copyright and reuse

All content is published under Creative Commons licensing, which enables authors to retain copyright while allowing others to copy, distribute, and make some uses of their work, provided full credit is given to them as originators. Authors will be offered a choice of two licences (CC BY or CC BY-NC-ND) depending on whether or not they wish to allow commercial reuse of their work and whether or not they wish to allow others to alter their work in the course of its reuse. Authors will be asked to sign an exclusive licence (or non-exclusive licence for government employees) to permit our publisher, Elsevier, to publish the work in The Lancet Public Health.

Publishing excellence

As trusted sources of information, the Lancet journals set extremely high standards for publishing, and we are committed to ensuring that our editorial processes meet our standards of excellence. From acceptance of your paper through to publication and beyond, our in-house teams of professional Editors, Assistant Editor, Illustrators, Production Editors, and Marketing and Communications experts can provide personal attention and guidance to strengthen the accuracy, accessibility, timeliness, and impact of your research.

About the Editorial team

Audrey Ceschia is the Editor-in-Chief. Audrey completed her PhD in Biology and Health in 2005 at the University of Montpellier, France. After working in cell biology as a post-doctoral scientist at the Clinical Science Center, Hammersmith Hospital, Imperial College, London, in 2008, she joined The Lancet journals, first as a Senior Editor for The Lancet Oncology in 2008 and then as a Senior Editor at The Lancet in 2013. Audrey has a broad interest in health, health policy, and current affairs. She has worked on a wide variety of health topics, with a broad public health and global health perspective (eg, cancer care in high-income countries, maternal health, FGM, and France’s health system).

John Carson is the Senior Editor. John completed his PhD in Ecology at the University of Edinburgh and went on to work as a post-doctoral research at the University of Reading. In 2016 he became one of the launch editors of the journal Nature Human Behaviour (NHB) and in his time there took on a broad portfolio of disciplines. After being promoted to Senior Editor at NHB, John developed a keen interest in research with real-world impacts, which lead him to take Public Health, Epidemiology, and Behavioural Medicine into his core areas of responsibility. John joined the team at The Lancet Public Health as a Senior Editor in 2019. He has a special interest in the power of behaviour change research and evidence-based health policy.

International Advisory Board

The advisory board of the journal consists of key opinion leaders who have lent their expertise and support to The Lancet Public Health.

Ombudsman

Our ombudsman can: investigate delays in handling submitted manuscripts; discourtesy; failure to follow outlined procedures; failure to take reasonable account of representations to us by authors and readers; and challenges to the publishing ethics of the journal. If you have concerns about any of the above, please first contact an editor or the editorial inbox [email protected]; an editor will then respond to you (often, an editor can respond satisfactorily). If you remain dissatisfied with our response, please contact Malcolm Molyneux ([email protected])

Read more about the ombudsman and see our ombudsman's reports.

The Lancet Group’s Diversity Pledge and No All-Male Panel Policy

Read the Diversity Pledge and No All-Male Panel Policy

November 2020
Volume 5, Issue 11